Corporate Attorney Charles Alovisetti Spoke on Cannabis M&A Licensing Pitfalls at Benzinga Cannabis Capital Conference
Jun 25, 2025
Vicente partner and co-chair of the firm’s Corporate Department Charles Alovisetti recently spoke at the Benzinga Cannabis Capital Conference in Chicago on June 9, 2025 during a panel discussion on licensing pitfalls in cannabis mergers and acquisitions.
When the Paperwork Stalls Your Deal: Avoiding Licensing Pitfalls in Cannabis M&A with Charles Alovisetti
In this session, Charlie discusses how licensing complications can delay, devalue, or derail cannabis M&A deals, regardless of how strong the fundamentals appear on paper. He will examine common regulatory obstacles, including hidden ownership restrictions and state-by-state transfer limitations, and share practical strategies to help dealmakers identify and mitigate these risks early in the transaction process.
Join Us at the Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference is one of the leading business and investment forums for cannabis executives, entrepreneurs and investors. The event features live presentations, expert panels, and extensive networking opportunities aimed at driving industry growth and innovation.
About Charlie Alovisetti
Charlie Alovisetti is a partner at Vicente LLP and co-chair of the firm's Corporate Department. He advises investors, companies, and other law firms on complex corporate transactions across highly regulated industries, with a particular depth of experience in cannabis, hemp, psychedelics, and emerging consumer products.
Extensive experience managing licensed transactions across major regulated markets provides Charlie with deep insight into state and local regulatory nuances, particularly regarding stock and asset acquisitions, management structures, and strategic investment planning. He also counsels emerging growth and portfolio companies on general corporate governance, commercial transactions, and compensation arrangements. Click here to learn more about Charlie.